What is he best known for?
The fields of study he is best known for:
Apoptosis, Cell biology, Programmed cell death, Cancer research and Puma are his primary areas of study.
His Apoptosis research integrates issues from Cell and Cytokine.
His Cell biology study combines topics from a wide range of disciplines, such as Carcinogenesis, Molecular biology and Suppressor.
The Programmed cell death study combines topics in areas such as Tumor suppressor gene, Neurodegeneration, DNA damage and Neuroscience.
His research integrates issues of Fas ligand, Immunology, BH3 Mimetic ABT-737 and Fas receptor in his study of Cancer research.
His Puma study integrates concerns from other disciplines, such as Cellular differentiation and Bcl-2 family.
His most cited work include:
- Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018. (1421 citations)
- p53- and drug-induced apoptotic responses mediated by BH3-only proteins puma and noxa. (1100 citations)
- p53- and drug-induced apoptotic responses mediated by BH3-only proteins puma and noxa. (1100 citations)
What are the main themes of his work throughout his whole career to date?
His scientific interests lie mostly in Cell biology, Apoptosis, Programmed cell death, Cancer research and Immunology.
His work carried out in the field of Cell biology brings together such families of science as Cell cycle, DNA damage and Puma.
Andreas Villunger combines subjects such as CHEK1, Cell cycle checkpoint, Death domain and DNA repair with his study of DNA damage.
His Apoptosis research is multidisciplinary, incorporating perspectives in Cell culture, Immune system and Molecular biology.
Andreas Villunger works in the field of Programmed cell death, namely Bcl-2 family.
The study incorporates disciplines such as Cytokine, Carcinogenesis, T cell, Downregulation and upregulation and B cell in addition to Cancer research.
He most often published in these fields:
- Cell biology (57.76%)
- Apoptosis (49.14%)
- Programmed cell death (42.24%)
What were the highlights of his more recent work (between 2018-2021)?
- Cell biology (57.76%)
- Cancer research (40.52%)
- Programmed cell death (42.24%)
In recent papers he was focusing on the following fields of study:
His primary scientific interests are in Cell biology, Cancer research, Programmed cell death, DNA damage and Centrosome.
His Cell biology study incorporates themes from Apoptosis, Cell cycle and Multiprotein complex.
Andreas Villunger regularly ties together related areas like Mutant in his Apoptosis studies.
His work deals with themes such as T cell, Entosis, Downregulation and upregulation and B cell, which intersect with Cancer research.
He mostly deals with Caspase in his studies of Programmed cell death.
His work focuses on many connections between DNA damage and other disciplines, such as CHEK1, that overlap with his field of interest in Essential gene and Haematopoiesis.
Between 2018 and 2021, his most popular works were:
- RIPK1 and Caspase-8 Ensure Chromosome Stability Independently of Their Role in Cell Death and Inflammation (21 citations)
- Glucocorticoid Receptor-Deficient Foxp3 + Regulatory T Cells Fail to Control Experimental Inflammatory Bowel Disease (15 citations)
- Glucocorticoid Receptor-Deficient Foxp3 + Regulatory T Cells Fail to Control Experimental Inflammatory Bowel Disease (15 citations)
In his most recent research, the most cited papers focused on:
The scientist’s investigation covers issues in Cell biology, Cytokinesis, Centrosome, Downregulation and upregulation and Cancer research.
His Cell biology research incorporates themes from DNA methylation, Immunoglobulin class switching, Reprogramming, Somatic hypermutation and Germinal center.
Andreas Villunger has researched Cytokinesis in several fields, including E2F Transcription Factors, Cell cycle, E2F, E2F1 and Cell fate determination.
His Centrosome research incorporates elements of Multiprotein complex, DNA damage, Neoplastic transformation, Regeneration and Ploidy.
His Downregulation and upregulation study combines topics in areas such as Inflammatory bowel disease, T cell, Immune system, Regulatory T cell and Glucocorticoid receptor.
His studies deal with areas such as Crosstalk, Venetoclax, Regulation of gene expression, FOXP3 and Glucocorticoid as well as Cancer research.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
